Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients

被引:13
作者
Marini, Valeria [1 ]
Fucile, Carmen [1 ]
Zuccoli, Maria Laura [1 ]
Testino, Giovanni [2 ]
Sumberaz, Alessandro [2 ]
Robbiano, Luigi [1 ]
Martelli, Antonietta [1 ]
Mattioli, Francesca [1 ]
机构
[1] Univ Genoa, Clin Pharmacol & Toxicol Unit, Dept Internal Med, I-16132 Genoa, Italy
[2] San Martino Hosp, Unit Hepatol & Alcohol Dis, I-16132 Genoa, Italy
关键词
OPRM1; Polymorphism; Alcoholism; Detoxification from alcohol dependence; ADDICTION; OPRM1; NALTREXONE; MARKERS; ABUSE;
D O I
10.1016/j.addbeh.2012.09.015
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: The All 8G (rs 1799971) polymorphism in the mu-opioid receptor gene (OPRM1) has been reported to be associated with alcohol addiction. Methods: In this study 109 patients diagnosed with alcohol dependence in accordance with DMS-IV criteria and 95 healthy subjects were enrolled and everyone has been genotyped. Results: The percentage of alcoholic patients with higher than normal gamma-glutamyl transferase (GGT) levels significantly decreased after six months of standard detoxification treatment, both in patients with A/A genotype and in the other ones with A/G genotype. However, the percentage of alcohol dependent patients with the A/A genotype recorded a slight decrease of the GGT and the mean corpuscolar volume of erythrocytes (MCV) combination marker after six months of therapy (30% vs 12%), while subjects with the A/G genotype showed no variation. Conclusion: This finding suggests that alcohol dependent patients with the A/A genotype could have a faster restoration of their liver function than those ones with the A/G genotype: it might be possible that the presence of G allele confers on these patients a reduced ability in abstaining from drinking alcohol. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1669 / 1671
页数:3
相关论文
共 12 条
[1]   Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity:: Possible implications for opiate addiction [J].
Bond, C ;
LaForge, KS ;
Tian, MT ;
Melia, D ;
Zhang, SW ;
Borg, L ;
Gong, JH ;
Schluger, J ;
Strong, JA ;
Leal, SM ;
Tischfield, JA ;
Kreek, MJ ;
Yu, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9608-9613
[2]   Traditional markers of excessive alcohol use [J].
Conigrave, KM ;
Davies, P ;
Haber, P ;
Whitfield, JB .
ADDICTION, 2003, 98 :31-43
[3]   Susceptibility for alcoholism:: DRD4 exon III polymorphism:: a case-control and a family-based association approach [J].
Franke, P ;
Wang, T ;
Nöthen, MM ;
Knapp, M ;
Neith, H ;
Lichtermann, D ;
Zur Capellen, KM ;
Sander, T ;
Propping, P ;
Maier, W .
ADDICTION BIOLOGY, 2000, 5 (03) :289-295
[4]   Endogenous opioids and addiction to alcohol and other drugs of abuse [J].
Gianoulakis, C .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (01) :39-50
[5]   Pharmacogenomics and addiction to opiates [J].
Lichtermann, D ;
Franke, P ;
Maier, W ;
Rao, ML .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 410 (2-3) :269-279
[6]   OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models [J].
Mague, Stephen D. ;
Blendy, Julie A. .
DRUG AND ALCOHOL DEPENDENCE, 2010, 108 (03) :172-182
[7]   A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients [J].
Oslin, DW ;
Berrettini, W ;
Kranzler, HR ;
Pettinati, H ;
Gelernter, J ;
Volpicelli, JR ;
O'Brien, CP .
NEUROPSYCHOPHARMACOLOGY, 2003, 28 (08) :1546-1552
[8]   A polymorphism of the μ-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans [J].
Ray, LA ;
Hutchison, KE .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (12) :1789-1795
[9]  
Sillanaukee P, 1996, ALCOHOL ALCOHOLISM, V31, P613
[10]   A comparison of the effects of 6-β naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats [J].
Stromberg, MF ;
Rukstalis, MR ;
Mackler, SA ;
Volpicelli, JR ;
O'Brien, CP .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 72 (1-2) :483-490